Chemotherapy combined with Kanglaite in treatment of advanced non-small cell lung cancer

Journal of Practical Oncology

Volumn 24, Issue 6, 2009, Pages 595-598

  Liao, Guo Qing ^a   Wang, Gui Wei ^a   Liu, Peng Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Carcinoma, non small cell lung zhong si yi jie he liao fa; Cisplatin therapeutic use; Drug therapy, combination; Injection; Lung neoplasms zhong si yi jie he liao fa; Semen coicis ther use; Vinblastine ther use

Indexed keywords

CISPLATIN; DEXAMETHASONE; KANGLAITE; NAVELBINE; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; QUALITY OF LIFE;

EID: 78650854742     PISSN: 10011692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Granville CA, Dennis PA. An overview of lung cancer genomics and proteomics [J]. Am J Respir Cell Mol Biol, 2005,32(3):169-175.
2. Morikawa K, Hosokawa M, Hamada J, et al. Possible participation of tumoricidal macrophage in the therapeutic effect of bleomycin on a transplantable rat fibrosaroma [J]. Cancer Res, 1996,46(2):684-688.
3. Sigstad E, Dong HP, Nielsen S, et al. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping [J]. Diagn Cytopathol, 2005,33(5):325-331.
4. + regulatory T lymphocytes in malignant pleural effusion [J]. Am J Resp Crit Care Med, 2005,172(11):1434-1439.